Statistics
Modeling of HIV-1 prophylactic efficacy and toxicity with islatravir shows non-superiority for oral dosing, but promise as a subcutaneous implant
| Views | |
|---|---|
| Modeling ... | 283 |
Total Visits Per Month
| May 2026 | June 2026 | July 2026 | August 2026 | September 2026 | October 2026 | November 2026 | |
|---|---|---|---|---|---|---|---|
| Modeling ... | 31 | 23 | 36 | 34 | 26 | 45 | 11 |
File Visits
| Views | |
|---|---|
| CPT Pharmacom Syst Pharma - 2024 - Kim - Modeling of HIV‐1 prophylactic efficacy and toxicity with islatravir shows.pdf | 102 |